0.40Open0.40Pre Close0 Volume122 Open Interest170.00Strike Price0.00Turnover232.95%IV129.68%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type0.0374Delta0.0026Gamma185.48Leverage Ratio-0.1014Theta0.0008Rho6.93Eff Leverage0.0108Vega
72623473 : No use, internal personnel will deliberately create various troubles! Such as fire, such as leaking, and so on... Then they bottom out! Full of routines...
Steven J : I bought $Concentrix (CNXC.US)$ ,$Advanced Micro Devices (AMD.US)$ at these low levels. Sold my $Axcelis Technologies (ACLS.US)$ at 136. I like that one too. But here one of my favorite and is very undervalued $Certara (CERT.US)$ and unappreciated by wallstreet.
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. The pipeline of getting drugs approved keeps going up and Biosimulation should be beneficiary. Do your own Homework